DE102013220974A1 - Zusammensetzung zur oralen Administration von Curcumin - Google Patents

Zusammensetzung zur oralen Administration von Curcumin Download PDF

Info

Publication number
DE102013220974A1
DE102013220974A1 DE201310220974 DE102013220974A DE102013220974A1 DE 102013220974 A1 DE102013220974 A1 DE 102013220974A1 DE 201310220974 DE201310220974 DE 201310220974 DE 102013220974 A DE102013220974 A DE 102013220974A DE 102013220974 A1 DE102013220974 A1 DE 102013220974A1
Authority
DE
Germany
Prior art keywords
curcumin
composition according
oil
weight
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE201310220974
Other languages
German (de)
English (en)
Inventor
Uwe-Bernd Rose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Briu GmbH
Original Assignee
Briu GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Briu GmbH filed Critical Briu GmbH
Priority to DE201310220974 priority Critical patent/DE102013220974A1/de
Priority to EP14801919.3A priority patent/EP3057578A1/fr
Priority to PCT/DE2014/200508 priority patent/WO2015055193A1/fr
Publication of DE102013220974A1 publication Critical patent/DE102013220974A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE201310220974 2013-10-16 2013-10-16 Zusammensetzung zur oralen Administration von Curcumin Withdrawn DE102013220974A1 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE201310220974 DE102013220974A1 (de) 2013-10-16 2013-10-16 Zusammensetzung zur oralen Administration von Curcumin
EP14801919.3A EP3057578A1 (fr) 2013-10-16 2014-09-26 Composition permettant l'administration orale de curcumine
PCT/DE2014/200508 WO2015055193A1 (fr) 2013-10-16 2014-09-26 Composition permettant l'administration orale de curcumine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE201310220974 DE102013220974A1 (de) 2013-10-16 2013-10-16 Zusammensetzung zur oralen Administration von Curcumin

Publications (1)

Publication Number Publication Date
DE102013220974A1 true DE102013220974A1 (de) 2015-04-16

Family

ID=51945662

Family Applications (1)

Application Number Title Priority Date Filing Date
DE201310220974 Withdrawn DE102013220974A1 (de) 2013-10-16 2013-10-16 Zusammensetzung zur oralen Administration von Curcumin

Country Status (3)

Country Link
EP (1) EP3057578A1 (fr)
DE (1) DE102013220974A1 (fr)
WO (1) WO2015055193A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110960516A (zh) * 2018-09-27 2020-04-07 广州汝丽多食品科技有限公司 一种姜黄素复合物及其制备方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441050B1 (en) * 2000-08-29 2002-08-27 Raj K. Chopra Palatable oral coenzyme Q liquid
CN1736369A (zh) * 2004-08-12 2006-02-22 山东绿叶天然药物研究开发有限公司 姜黄素乳剂及其制备方法和用途
JP2011079786A (ja) * 2009-10-08 2011-04-21 Sankyo:Kk 崩壊遅延を防止または抑制したポリフェノール類、レシチン、ビタミンｅ含有ソフトカプセル
CN102552820A (zh) * 2012-02-17 2012-07-11 神威药业有限公司 一种制备降脂通络软胶囊的方法
WO2013086327A1 (fr) * 2011-12-08 2013-06-13 Abbott Laboratories Compositions nutritionnelles comprenant de la curcumine et de l'acide phosphatidylsérine-docosahexaènoïque pour améliorer la cognition
WO2013111066A2 (fr) * 2012-01-26 2013-08-01 Fidia Farmaceutici S.P.A. Nouvelles compositions pharmaceutiques contenant de la phosphatidylsérine et du curcumine
WO2013176555A1 (fr) * 2012-05-22 2013-11-28 Cave Harold Gordon Complexes améliorés et compositions contenant de la curcumine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1283237C (zh) * 2004-11-22 2006-11-08 山东大学 姜黄素磷脂复合物及其制备方法
ITMI20072315A1 (it) * 2007-12-11 2009-06-12 Bios Line Spa Composizioni orali per la prevenzione e il trattamento dei disturbi del colon su base infiammatoria

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441050B1 (en) * 2000-08-29 2002-08-27 Raj K. Chopra Palatable oral coenzyme Q liquid
CN1736369A (zh) * 2004-08-12 2006-02-22 山东绿叶天然药物研究开发有限公司 姜黄素乳剂及其制备方法和用途
JP2011079786A (ja) * 2009-10-08 2011-04-21 Sankyo:Kk 崩壊遅延を防止または抑制したポリフェノール類、レシチン、ビタミンｅ含有ソフトカプセル
WO2013086327A1 (fr) * 2011-12-08 2013-06-13 Abbott Laboratories Compositions nutritionnelles comprenant de la curcumine et de l'acide phosphatidylsérine-docosahexaènoïque pour améliorer la cognition
WO2013111066A2 (fr) * 2012-01-26 2013-08-01 Fidia Farmaceutici S.P.A. Nouvelles compositions pharmaceutiques contenant de la phosphatidylsérine et du curcumine
CN102552820A (zh) * 2012-02-17 2012-07-11 神威药业有限公司 一种制备降脂通络软胶囊的方法
WO2013176555A1 (fr) * 2012-05-22 2013-11-28 Cave Harold Gordon Complexes améliorés et compositions contenant de la curcumine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ullmann's Encyclopedia of Industrial Chemistry, 6. Auflage, Band 39, Seite 135 ff

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110960516A (zh) * 2018-09-27 2020-04-07 广州汝丽多食品科技有限公司 一种姜黄素复合物及其制备方法
CN110960516B (zh) * 2018-09-27 2023-01-06 广州汝丽多食品科技有限公司 一种姜黄素复合物及其制备方法

Also Published As

Publication number Publication date
WO2015055193A1 (fr) 2015-04-23
EP3057578A1 (fr) 2016-08-24

Similar Documents

Publication Publication Date Title
DE10196213B4 (de) Verwendung von Tetrahydropiperin zur Erhöhung der Bioverfügbarkeit von Nährstoffen und pharmazeutischen Präparationen
EP3300722B1 (fr) Composition contenant du cinéol destinée à l'administration nasale
DD206324A5 (de) Verfahren zur herstellung antiherpetisch wirksamer lippenstifte
US20160256513A1 (en) Synergized turmeric
WO2019011955A2 (fr) Solubilisat contenant de la curcumine et optionnellement au moins une autre substance active
DE212016000151U1 (de) Zusammensetzung mit Mangostanrindenextrakt zur Behandlung von Hautkrankheiten
DE102004030044A1 (de) Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels
EP1591125A1 (fr) Composition pharmaceutique comprenant des extraits des lichens et d'hypericum
EP2579862B1 (fr) Composition pharmaceutique intranasale contenant un extrait d'olive (hydroxytyrosol) et un extrait de houblon (xanthohumol)
DE102013220974A1 (de) Zusammensetzung zur oralen Administration von Curcumin
EP3142641B1 (fr) Formulations pour traiter l'hyperthyroïdie
EP2817002B1 (fr) Combinaison de protéines de transfert lipidique et de dérivés phénoliques contenant des substances végétales localement efficaces sur les muqueuses
EP1503772B1 (fr) Composition soluble contenant de la sporopollenine et utilisation de ladite composition
EP2908836B1 (fr) Formulation pharmaceutique contenant du curcuma
EP3297603B1 (fr) Composition aqueuse contenant du cinéol pour application nasale
DE202020104968U1 (de) Sprühfähige Zusammensetzung eines Rachensprays
DE102006038471A1 (de) Platanencreme, Verfahren zu ihrer Herstellung und Verwendung
EP2142015A2 (fr) Préconcentrés en émulsion et préparations micellaires contenant de la résine de bois
EP3359120B1 (fr) Solution stable des sels de hexamidine dans des melanges d'alcanediol et d'eau avec acitivité antimicrobielle et humidifié de la peau
DE202012000910U1 (de) Systemische Darreichungsformen mit kontrollierter Freisetzung und verbesserter Stabilität
LU102146B1 (de) Sprühfähige Zusammensetzung eines Rachensprays
EP0834312A1 (fr) Préparation topique à base de diclofonac
WO2022254014A1 (fr) Nouvelle nanoémulsion huile-dans-eau
EP4209207A1 (fr) Composition comprenant une phase polaire et une phase non polaire
CH699449A2 (de) Emulsionsvorkonzentrate sowie micellare Formulierungen enthaltend Glycerinfettsäureester.

Legal Events

Date Code Title Description
R012 Request for examination validly filed
R082 Change of representative

Representative=s name: PATENT- UND RECHTSANWAELTE ULLRICH & NAUMANN P, DE

R082 Change of representative

Representative=s name: PATENT- UND RECHTSANWAELTE ULLRICH & NAUMANN P, DE

R082 Change of representative

Representative=s name: PATENT- UND RECHTSANWAELTE ULLRICH & NAUMANN P, DE

R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee
R409 Internal rectification of the legal status completed
R409 Internal rectification of the legal status completed
R016 Response to examination communication
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee